Siegel RL, Miller KD, Sauer AG, et al. - By this comprehensive overview, researchers intended to provide current colorectal cancer (CRC) statistics in the United States, covering the numbers of novel cases and deaths in 2020 by age and incidence, survival, and mortality rates, as well as trends by age and race/ethnicity. For this purpose, they used incidence data through 2016 and mortality data through 2017. As expected based on the estimates, a diagnosis of CRC will be received by about 147,950 people and deaths attributable to CRC will be 53,200, in 2020, including 17,930 cases and 3,640 deaths in people aged younger than 50 years. From 2012 through 2016, the incidence rate was reported to be 30 (per 100,000 persons) in Asian/Pacific Islanders, 45.7 in blacks, and 89 in Alaska Natives. As for CRC death rates, during 2008 through 2017, an annual drop by 3% was reported among people aged 65 years and older and an annual drop by 0.6% was noted in people aged 50 to 64 years while it rose by 1.3% yearly among those aged younger than 50 years. Mortality reductions in people aged 50 years and older were steepest in blacks, who also had the only declining trend in those aged younger than 50 years, and eliminated American Indians/Alaska Natives, in whom rates continued to be stable. Based on these revelations, it was inferred that by improving access to guideline-recommended screening and high-quality treatment, especially among Alaska Natives, and clarifying reasons for increasing incidence in young and middle-aged adults, accelerated progress against CRC can be ensured.